logo-loader
ASX:ATX

Amplia Therapeutics Ltd

Receive alerts
Market:
ASX
Price
0.08 AUD
Day Change
-
Market Cap:
$14.94 m
52 weeks high
0.12
52 weeks low
0.06

In brief

Amplia Therapeutics Ltd (ASX:ATX) is focused on advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis.

FAK is an increasingly important target in the field of cancer immunology and Amplia has a particular development focus in pancreatic and ovarian cancer.